Please ensure Javascript is enabled for purposes of website accessibility
REVIEW PAPER
Nutritional problems among patients affected by cancer during chemotherapy
 
More details
Hide details
 
Submission date: 2015-06-02
 
 
Final revision date: 2015-10-02
 
 
Acceptance date: 2015-12-11
 
 
Publication date: 2016-01-11
 
 
Medical Studies 2015;31(4):295-299
 
KEYWORDS
TOPICS
ABSTRACT
Chemotherapy is one of the primary methods of treating cancer. Symptoms occurring during this form of therapy affect patients’ general health status, cause malnutrition, and deteriorate the quality of life of oncology patients, which results in cachexia. Malnutrition during treatment and the resulting bad general health status of patients may lead to disqualification from chemotherapy treatment. Cachexia is a complex and multi-factorial process, characterised by the nearly unknown mechanism of its development. What is extremely crucial is the evaluation of the state of malnutrition among patients qualified for cytostatic therapy and regular control of this state during therapy and immediately after its termination. Clinical practice indicates the importance of applying pharmacotherapy, nutritional treatment, and targeted education for the patient and their closest family regarding diet and correct behaviour, which significantly reduces anxiety and stress.
REFERENCES (29)
1.
Pawlicki M, Rolski J, Wiczyńska B. Odległe powikłania leczenia systemowego nowotworów. In: Onkologia kliniczna. Krzakowski M (ed.). Wyd. Med. Borgis, Warsaw 2001.
 
2.
Dos Santos CA, Rosa COB, Ribeiro AQ, et al. Patient-generated subjective global assessment and classic anthropometry: comparison between the methods in detection of malnutrition among elderly with cancer. Nutr Hosp 2015; 31 (Suppl. 1): 384-92.
 
3.
Lee HO, Lee JJ. Nutritional intervention using nutrition care process in a malnourished patient with chemotherapy side effects. Clin Nutr Res 2015; 4: 63-7.
 
4.
Klein GL, Petschow BW, Shaw AL, et al. Gut barrier dysfunction and microbial translocation in cancer cachexia: a new therapeutic target. Curr Opin Support Palliat Care 2013; 7 (Suppl. 4): 361-7.
 
5.
Mendes MCS, Pimentel GD, Costa FO, et al. Molecular and neuroendocrine mechanisms of cancer cachexia. J Endocrinol 2015; 226 (Suppl. 3): R29-43.
 
6.
Aoyagi T, Terracina KP, Raza A, et al. Cancer cachexia, mechanism and treatment. World J Gastrointest Oncol 2015; 7 (Suppl. 4): 17-29.
 
7.
Mueller TC, Burmeister MA, Bachmann J, et al. Cachexia and pancreatic cancer: are there treatment options? World J Gastroenterol 2014; 20 (Suppl. 28): 9361-73.
 
8.
Stephens NA, Skipworth RJE, Gallagher IJ, et al. Evaluating potential biomarkers of cachexia and survival in skeletal muscle of upper gastrointestinal cancer patients. J Cachexia Sarcopeni 2015; 6: 53-61.
 
9.
Halsted C, Brunwald E, Fauci A, et al. Nutritional requirements and dietary assessment. In: Harrison’s principles of internal medicine. 15th ed. McGraw- Hill, New York 2001; 455-60.
 
10.
Dev R, Hui D, Chisholm G, et al. Hypermetabolism and symptom burden in advanced cancer patients evaluated in a cachexia clinic. J Cachexia Sarcopeni 2015; 6: 95-8.
 
11.
Johns N, Tan BH, MacMillan M, et al. Genetic basis of interindividual susceptibility to cancer cachexia: selection of potential candidate gene polymorphisms for association studies. J Genet 2014; 93 (Suppl. 3): 893-916.
 
12.
Onesti JK, Guttridge DC. Inflammation based regulation of cancer cachexia. Biomed Res Int 2014; 2014: 1-7.
 
13.
Stefanek ME. Psychosocial aspects of breast cancer. Curr Opin Oncol 1992; 4/6: 1055-60.
 
14.
Reid J. Psychosocial, educational and communicative interventions for patients with cachexia and their family carers. Curr Opin Support Palliat Care 2014; 8 (Suppl. 4): 334-8.
 
15.
Kapała A, Lange E. Possibility of pain reduction by dietary intervention in patients with advanced cancer. Ann Agric Environ Med 2013; 1: 18-22.
 
16.
Cooper C, Burden ST, Cheng H, et al. Understanding and managing cancer-related weight loss and anorexia: insights from a systematic review of qualitative research. J Cachexia Sarcopeni 2015; 6: 99-111.
 
17.
Friesen DE, Baracos VE, Tuszynski JA. Modeling the energetic cost of cancer as a result of altered energy metabolism: implications for cachexia. Theor Biol Med Model 2015; 12 (Suppl. 17): 1-18.
 
18.
Barendregt K, Soeters BP, Allison PS, et al. Rozpoznawanie niedożywienia – badania przesiewowe i ocena pogłębiona. In: Podstawy żywienia klinicznego. Sobotka L, Korta T, Łyszkowska M (ed.). PZWL, Warsaw 2004; 11-9.
 
19.
Szczygieł B. Żywienie w chirurgii. In: Podstawy chirurgii. Szmidt J (ed.). Wydawnictwo Medycyna Praktyczna, Krakow 2003; 265-90.
 
20.
Szczygieł B. Leczenie żywieniowe. In: Przegląd Piśmiennictwa Chirurgicznego 2003. Noszczyk W (ed.). Fundacja Polski Przegląd Chirurgiczny 2004; XI: 424-35.
 
21.
Szczygieł B. Leczenie żywieniowe – postępy w 2008 roku. Med Prakt Chir 2009; 1: 39-48.
 
22.
Szczygieł B. Leczenie żywieniowe chorych na nowotwory. Nowotwory 2007; 57 (Suppl. 1): 1-8.
 
23.
Krawczyk J, Świeboda-Sadlej A. Interwencje żywieniowe u chorych na nowotwory. 2010; 14 (Suppl. 6): 397-402.
 
24.
Szczygieł B. Pogłębiona ocena stanu odżywienia. Badania antropometryczne. In: Niedożywienie związane z chorobą. Szczygieł B (ed.). PZWL, Warsaw 2011; 29-38.
 
25.
ESPEN Guidelines on Enteral Nutrition. Clin Nutr 2006; 25: 245-59.
 
26.
Kłęk S. Leczenie żywieniowe w onkologii. Onkol Prakt Klin 2011; 7 (Suppl. 5): 269-73.
 
27.
Jarosz J. Wyniszczenie nowotworowe. Medycyna Paliatywna 2002; 1: 3-8.
 
28.
Strasser F, Bruera ED. Update on anorexia and cachexia. Hematol Onco Clin North Am 2002; 16 (Suppl. 3): 589-617.
 
29.
Del Fabbro E. Current and future care of patients with the cancer anorexia-cachexia syndrome. Am Soc Clin Oncol Educ Book 2015; 35: 229-37.
 
eISSN:2300-6722
ISSN:1899-1874
Journals System - logo
Scroll to top